TSE:TH Theratechnologies (TH) Stock Price, News & Analysis C$2.00 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's RangeC$1.95▼C$2.0550-Day RangeC$1.66▼C$2.1652-Week RangeC$1.22▼C$4.45Volume15,200 shsAverage Volume28,200 shsMarket CapitalizationC$91.96 millionP/E RatioN/ADividend Yield3.76%Price TargetC$5.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades Get Theratechnologies alerts: Email Address Theratechnologies MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside175.0% UpsideC$5.50 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.81 out of 5 stars 3.3 Analyst's Opinion Consensus RatingTheratechnologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageTheratechnologies has received no research coverage in the past 90 days.Read more about Theratechnologies' stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for TH. Previous Next 1.7 Dividend Strength Dividend LeadershipTheratechnologies is a leading dividend payer. It pays a dividend yield of 3.76%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthTheratechnologies does not have a long track record of dividend growth.Read more about Theratechnologies' dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TH. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Theratechnologies this week, compared to 1 article on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Theratechnologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.29% of the stock of Theratechnologies is held by insiders.Percentage Held by Institutions48.93% of the stock of Theratechnologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Theratechnologies' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Theratechnologies is -2.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Theratechnologies is -2.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDue to a projected decrease in earnings for Theratechnologies, their PEG ratio cannot be calculated.Read more about Theratechnologies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyNvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.To see Porter Stansberry's new AI prediction go here now. About Theratechnologies Stock (TSE:TH)Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.Read More TH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TH Stock News HeadlinesJuly 24 at 2:04 PM | theglobeandmail.comClosing Bell: Theratechnologies flat on Tuesday (TH)May 23, 2024 | finance.yahoo.comTheratechnologies Up Near 5% In US After Hours On Data Related To Its Lead Investigational Peptide Drug Conjugate CandidateJuly 26, 2024 | Paradigm Press (Ad)Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.April 14, 2024 | theglobeandmail.comTheratechnologies: Top 10 Undervalued Biotechnology Industry Stocks (TH)April 10, 2024 | msn.comU.S. Index Futures Show Mixed Trend Ahead of Key Inflation Data Release, Oil Prices Edge HigherApril 9, 2024 | stockhouse.comTheratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology(TM) Oncology PlatformMarch 11, 2024 | msn.comNurse-Led Strategy Reduces Cardiovascular Risk Factors for People With HIVFebruary 27, 2024 | morningstar.comTheratechnologies Shares Sink Premarket After FDA Refusal to File LetterJuly 26, 2024 | Paradigm Press (Ad)Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.February 27, 2024 | seekingalpha.comTheratechnologies stock plunges after FDA denies review of Trogarzo sBLAFebruary 23, 2024 | finance.yahoo.comTheratechnologies Full Year 2023 Earnings: Misses ExpectationsFebruary 21, 2024 | finance.yahoo.comTheratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 GuidanceFebruary 21, 2024 | markets.businessinsider.comHere's what Wall Street expects from Theratechnologies's earnings reportFebruary 20, 2024 | benzinga.com7THTX : Theratechnologies Earnings PreviewFebruary 20, 2024 | finance.yahoo.comTheratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of ActionFebruary 6, 2024 | finance.yahoo.comTheratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business UpdateJanuary 31, 2024 | finance.yahoo.comPositive Signs As Multiple Insiders Buy Theratechnologies StockJanuary 25, 2024 | msn.comFDA denies approval for Theratechnologies’ tesamorelin F8See More Headlines Receive TH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/10/2024Today7/26/2024Next Earnings (Estimated)9/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryRestaurants, Hotels, Motels Current SymbolTSE:TH CUSIPN/A CIKN/A Webwww.theratech.com Phone+1-514-3367800FaxN/AEmployees820Year FoundedN/APrice Target and Rating Average Stock Price TargetC$5.50 High Stock Price TargetC$5.50 Low Stock Price TargetC$5.50 Potential Upside/Downside+172.3%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.79) Trailing P/E RatioN/A Forward P/E Ratio63.05 P/E Growth-8.5Net IncomeC$-18,000,000.00 Net Margins-23.04% Pretax MarginN/A Return on Equity-1,116.86% Return on Assets-4.55% Debt Debt-to-Equity Ratio562.07 Current Ratio1.15 Quick Ratio0.64 Sales & Book Value Annual SalesC$78.10 million Price / Sales1.19 Cash FlowC$0.54 per share Price / Cash Flow3.76 Book ValueC($0.54) per share Price / Book-3.74Miscellaneous Outstanding Shares45,980,000Free FloatN/AMarket CapC$92.88 million OptionableNot Optionable Beta1.81 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Paul Lévesque (Age 59)President, CEO & Director Comp: $1.6MMr. Philippe Dubuc M.B.A. (Age 57)MBA, Senior VP & CFO Comp: $587.17kMr. Jocelyn Lafond L.L.M. (Age 56)LL.B., General Counsel & Corporate Secretary Comp: $429.6kDr. Christian Marsolais Ph.D. (Age 61)Senior VP & Chief Medical Officer Comp: $590.29kMr. John Leasure (Age 59)Global Commercial Officer Comp: $571.68kHon. Andre Dupras M.Sc. (Age 60)Vice President of Human Resources More ExecutivesKey CompetitorsCENTRIC HEALTHTSE:CHHManado GoldCVE:MDOBoyd Group ServicesTSE:BYDProMetic Life SciencesTSE:PLIVIVO CannabisCVE:ABCNView All CompetitorsInsidersDale WeilBought 36,200 shares on 11/1/2023Total: C$49,956.00 ($1.38/share)Joseph ArenaBought 10,000 shares on 10/30/2023Total: C$9,250.00 ($0.93/share)Dawn SvoronosBought 15,800 shares on 10/27/2023Total: C$21,646.00 ($1.37/share)Philippe DubucBought 8,000 shares on 10/27/2023Total: C$10,855.20 ($1.36/share)View All Insider Transactions TH Stock Analysis - Frequently Asked Questions How have TH shares performed this year? Theratechnologies' stock was trading at C$2.14 at the beginning of 2024. Since then, TH stock has decreased by 6.5% and is now trading at C$2.00. View the best growth stocks for 2024 here. How were Theratechnologies' earnings last quarter? Theratechnologies Inc. (TSE:TH) issued its quarterly earnings data on Wednesday, July, 10th. The company reported $0.03 earnings per share (EPS) for the quarter. The firm had revenue of $30 million for the quarter. Theratechnologies had a negative net margin of 23.04% and a negative trailing twelve-month return on equity of 1,116.86%. How do I buy shares of Theratechnologies? Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Theratechnologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Theratechnologies investors own include Stars Group (TSGI), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Nemaska Lithium (NMX). This page (TSE:TH) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theratechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theratechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TH Stock Alerts